Dr. Eric Winer, MD

• Medical Oncology

*Healthgrades does not verify qualifications for medical specialties. Please verify your provider's specialty and qualifications directly with your provider and applicable medical board.

• University Of New Mexico / Main Campus

  Medical School, 1999

• English

• Spanish

• A prospective trial of treatment de-escalation following neoadjuvant paclitaxel/trastuzumab/pertuzumab in HER2-positive breast cancer, 2022-05-10

• The impact of tumor epithelial and microenvironmental heterogeneity on treatment responses in HER2+breast cancer, 2021-06-08

• Extended adjuvant endocrine therapy in a longitudinal cohort of young breast cancer survivors, 2023-04-25

• Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer, 2021-09-21

• Combination antiangiogenic therapy in advanced breast cancer: a phase 1 trial of vandetanib, a VEGFR inhibitor, and metronomic chemotherapy, with correlative platelet proteomics, 2012-09-23

• Should a Sentinel Node Biopsy Be Performed in Patients with High-Risk Breast Cancer?, 2011-08-10

• Genomic characterization of brain metastases reveals branched evolution and potential therapeutic targets, 2015-09-26

• Cabozantinib for metastatic breast carcinoma: results of a phase II placebo-controlled randomized discontinuation study, 2016-10-06

• Clinical efficacy and molecular response correlates of the WEE1 inhibitor adavosertib combined with cisplatin in patients with metastatic triple-negative breast cancer (mTNBC), 2020-11-30

• Allele-specific chromatin recruitment and therapeutic vulnerabilities of ESR1 activating mutations, 2018-02-12

• Time to Diagnosis and Breast Cancer Stage by Race/Ethnicity, 2012-10-26

• Diet and physical activity interventions in Black and Latina women with breast cancer: A scoping review, 2023-03-13